The PATHWAYS puberty blocker trial is not ‘following the Cass Review’

Image by freepik Patient safety and evidence-based care must be the priority for the NHS regarding medical interventions for children. The PATHWAYS puberty blocker trial is not a prioritisation of…

Continue ReadingThe PATHWAYS puberty blocker trial is not ‘following the Cass Review’